Home » Topics » BioWorld Science

BioWorld Science
RSS

Cystistat covered under U.S. patent

July 12, 1996

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

NovoSeven hits U.K. market

July 12, 1996

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

Bristol-Myers Squibb's Pravachol cleared by FDA for new indication

July 12, 1996

Teijin's prostaglandin MCP-1/MCAF inhibitors

July 12, 1996

Smooth muscle cell proliferation inhibitors described by American Home Products

July 12, 1996

NEP inhibition research findings

July 12, 1996

Endothelin antagonists part of Fujisawa's pipeline

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...